RUBY

Rubius Therapeutics, Inc

Delisted

RUBY was delisted on the 6th of March, 2023.

72 hedge funds and large institutions have $66.6M invested in Rubius Therapeutics, Inc in 2022 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 19 increasing their positions, 28 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
72
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$34K
Puts
$1K
Net Calls
Net Calls Change

Top Buyers

1 +$605K
2 +$345K
3 +$333K
4
Two Sigma Investments
Two Sigma Investments
New York
+$288K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$262K

Top Sellers

1 -$16.2M
2 -$5.45M
3 -$2.29M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$2.13M
5
BlackRock
BlackRock
New York
-$1.77M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$32.7M
2
$11.5M
3
$4.17M
4
$3.15M
5
$1.88M
6
$1.65M
7
$1.21M
8
$1.2M
9
$840K
10
$777K
11
$703K
12
$564K
13
$560K
14
$479K
15
$474K
16
$370K
17
$362K
18
$345K
19
$301K
20
$300K
21
$298K
22
$244K
23
$238K
24
$186K
25
$182K